Geno
|
Mag
|
Summary
|
(A;G)
|
6
|
considered a causal BRCA2 breast cancer mutation
|
(C;G)
|
6
|
BRCA2 variant considered pathogenic for breast cancer
|
(G;G)
|
0
|
common in clinvar
|
(G;T)
|
6
|
BRCA2 variant considered pathogenic for breast cancer
|
rs28897743, also known as 7235G>T, c.7007G>T and p.Gly2313AlafsX31, as well as Arg2336His or R2336H, is a variant in the BRCA2 gene considered pathogenic for breast cancer in ClinVar and UMD.
This variant meets the criteria published in 2013 by the ACMG regarding incidental findings in exome or genome sequencing, as a variant that they do recommend informing a patient about.[PMID 23788249]
23andMe has another SNP for this position, named i5009343.
ClinVar
|
Risk
|
rs28897743(A;A) rs28897743(C;C) rs28897743(T;T) |
Alt
|
rs28897743(A;A) rs28897743(C;C) rs28897743(T;T) |
Reference
|
Rs28897743(G;G) |
Significance |
Pathogenic |
Disease |
Fanconi anemia Breast-ovarian cancer Hereditary breast and ovarian cancer syndrome Hereditary cancer-predisposing syndrome not provided not specified Familial cancer of breast |
Variation | info |
---|
Gene |
BRCA2 |
CLNDBN |
Fanconi anemia, complementation group D1 Breast-ovarian cancer, familial 2 Hereditary breast and ovarian cancer syndrome Hereditary cancer-predisposing syndrome not provided not specified Familial cancer of breast |
Reversed |
0 |
HGVS |
NC_000013.10:g.32921033G>A; NC_000013.10:g.32921033G>C; NC_000013.10:g.32921033G>T |
CLNSRC |
OMIM Allelic Variant Breast Cancer Information Core (BRCA2) |
CLNACC |
RCV000009923.4, RCV000031659.5, RCV000045112.5, RCV000131031.3, RCV000174440.4, RCV000259151.1, RCV000475925.1, RCV000045113.3, RCV000077394.3, RCV000214499.1, RCV000256059.1, RCV000475905.1, RCV000045114.3, RCV000113685.1, RCV000219635.1, |